Manufacturing, Nucleic Acids

Latest News

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Lilly Forms Strategic Collaboration with ViaNautis Bio to Develop Novel Genetic Cargo-based Therapeutics

October 30th 2024

The collaboration aims to develop precision genetic medicines using ViaNautis’ proprietary polyNaut technology platform.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Merck KGaA Set to Acquire Mirus Bio in $600 Million Deal

By Feliza Mirasol

May 23rd 2024

Astellas and Poseida Therapeutics Partner to Develop Allogeneic Cell Therapies

By Feliza Mirasol

May 6th 2024

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Charles River Enters pDNA Manufacturing Deals with Axovia Therapeutics and Ship of Theseus

By Feliza Mirasol

April 10th 2024

Single strand ribonucleic acid, RNA research and therapy | Image Credit: © nobeastsofierce - © nobeastsofierce/Stock.Adobe.com

Driving Innovation in Nucleic Acid Therapeutics

By Patrick Thiaville

April 2nd 2024

More News

Managing Cell Line Instability and Its Impact During Cell Line Development

Mark Leonard;Megan Hone;Cecilia Cooley;Kevin Mccarthy;Kerstin Crowe;Robin A. Heller-Harrison

June 2nd 2009

By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.

Production Strategies for Antibody Fragment Therapeutics

J.M. Liddell, PhD

June 2nd 2009

Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.

Recombinant Protein Production Yields from Mammalian Cells: Past, Present, and Future

Sophie Nallet;Florian M. Wurm, PhD;David L. Hacker, PhD

June 2nd 2008

A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.

<1 2 3